CN101769932A - 全量程c反应蛋白检测试剂盒 - Google Patents
全量程c反应蛋白检测试剂盒 Download PDFInfo
- Publication number
- CN101769932A CN101769932A CN201010103429A CN201010103429A CN101769932A CN 101769932 A CN101769932 A CN 101769932A CN 201010103429 A CN201010103429 A CN 201010103429A CN 201010103429 A CN201010103429 A CN 201010103429A CN 101769932 A CN101769932 A CN 101769932A
- Authority
- CN
- China
- Prior art keywords
- reactive protein
- reagent
- range
- full
- detection kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100032752 C-reactive protein Human genes 0.000 title claims abstract description 72
- 108010074051 C-Reactive Protein Proteins 0.000 title claims abstract description 70
- 238000002331 protein detection Methods 0.000 title claims abstract description 14
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000004816 latex Substances 0.000 claims abstract description 64
- 229920000126 latex Polymers 0.000 claims abstract description 64
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 49
- 239000007853 buffer solution Substances 0.000 claims abstract description 4
- 239000002245 particle Substances 0.000 claims description 39
- 238000013016 damping Methods 0.000 claims description 17
- 239000012530 fluid Substances 0.000 claims description 17
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 6
- 206010070834 Sensitisation Diseases 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- 230000008313 sensitization Effects 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 claims description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 239000008351 acetate buffer Substances 0.000 claims description 2
- 239000011545 carbonate/bicarbonate buffer Substances 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 238000005259 measurement Methods 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000001235 sensitizing effect Effects 0.000 abstract 1
- 238000002835 absorbance Methods 0.000 description 14
- 238000001514 detection method Methods 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 208000019553 vascular disease Diseases 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000004520 agglutination Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
- 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
- 208000010266 Aggressive Periodontitis Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 238000011546 CRP measurement Methods 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 102000012192 Cystatin C Human genes 0.000 description 1
- 108010061642 Cystatin C Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 description 1
- 201000006727 periodontosis Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
CRP(mg/L) | 测定次数 | 均值 | 2.6SD | M+2.6SD | M-2.6SD |
0 | 10 | 0.0000 | 0.031 | 0.05 | -0.02 |
CRP(mg/L) | 测定次数 | 均值 | 2.6SD | M+2.6SD | M-2.6SD |
0.1 | 10 | 0.0904 | 0.044 | 0.10 | 0.01 |
0.2 | 10 | 0.1878 | 0.056 | 0.16 | 0.04 |
0.3 | 10 | 0.2915 | 0.058 | 0.21 | 0.08 |
0.4 | 10 | 0.3977 | 0.044 | 0.23 | 0.12 |
0.5 | 10 | 0.4912 | 0.032 | 0.25 | 0.15 |
CRP理论值(mg/L) | CRP实际值(mg/L) | |
1 | 0 | 0.11 |
2 | 50 | 51.24 |
3 | 100 | 101.78 |
4 | 150 | 152.41 |
5 | 200 | 200.6 |
6 | 250 | 248.9 |
7 | 300 | 302.0 |
8 | 350 | 348.7 |
9 | 400 | 492.9 |
10 | 450 | 421.3 |
样品1 | 样品2 | |
测定次数 | 20 | 20 |
平均值(mg/L) | 1.21 | 80.25 |
最小值(mg/L) | 1.15 | 79.88 |
最大值(mg/L) | 1.26 | 81.70 |
标准差(SD) | 0.055 | 2.590 |
变异系数(CV%) | 4.55 | 3.23 |
批间精密度 | 样品1 | 样品2 |
测定次数 | 20 | 20 |
平均值(mg/L) | 1.25 | 80.11 |
最小值(mg/L) | 1.19 | 79.80 |
最大值(mg/L) | 1.24 | 81.77 |
标准差(SD) | 0.093 | 4.638 |
变异系数(CV%) | 7.42 | 5.79 |
项目 | 0月 | 4月 | 8月 | 12月 | 14月 |
试剂空白吸光度A0 | 0.6875 | 0.6789 | 0.6899 | 0.6901 | 0.6887 |
样本测得值(%) | 21.60 | 22.11 | 22.05 | 21.98 | 21.77 |
批内CV(%) | 1.25 | 1.09 | 1.48 | 1.65 | 2.15 |
吸光度均值 | 吸光度最小值 | 吸光度最大值 | 吸光度标准差 | 日间变异CV(%) |
0.6854 | 0.6785 | 0.6972 | 4.4551 | 6.5 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010103429 CN101769932B (zh) | 2010-01-26 | 2010-01-26 | 全量程c反应蛋白检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010103429 CN101769932B (zh) | 2010-01-26 | 2010-01-26 | 全量程c反应蛋白检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101769932A true CN101769932A (zh) | 2010-07-07 |
CN101769932B CN101769932B (zh) | 2013-09-18 |
Family
ID=42502921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010103429 Active CN101769932B (zh) | 2010-01-26 | 2010-01-26 | 全量程c反应蛋白检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101769932B (zh) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102565419A (zh) * | 2011-12-26 | 2012-07-11 | 宁波美康生物科技股份有限公司 | 肌红蛋白检测试剂盒 |
CN102590497A (zh) * | 2012-01-13 | 2012-07-18 | 宁波美康生物科技股份有限公司 | 胱氨酸蛋白酶抑制剂c检测试剂盒 |
CN102680698A (zh) * | 2011-07-29 | 2012-09-19 | 南京诺尔曼生物技术有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白(ngal)测定试剂盒(胶乳增强免疫比浊法) |
CN102809654A (zh) * | 2012-08-23 | 2012-12-05 | 上海睿康生物科技有限公司 | 一种双粒子复合的c-反应蛋白检测试剂盒 |
CN102841206A (zh) * | 2011-06-22 | 2012-12-26 | 南京诺尔曼生物技术有限公司 | 肌钙蛋白T(Troponin-T,TNT)测定试剂盒 |
CN102955033A (zh) * | 2012-10-22 | 2013-03-06 | 金华市强盛生物科技有限公司 | 一种测定人血液中甘胆酸的试剂盒 |
CN102998445A (zh) * | 2012-12-12 | 2013-03-27 | 元升生物科技(上海)有限公司 | 一种测定甘胆酸的试剂及制备方法 |
CN103018464A (zh) * | 2012-12-12 | 2013-04-03 | 元升生物科技(上海)有限公司 | 一种测定降钙素原的试剂及该试剂的制备方法 |
CN103033629A (zh) * | 2012-12-12 | 2013-04-10 | 元升生物科技(上海)有限公司 | 一种脂蛋白磷脂酶a2的测定试剂及试剂的制备方法 |
CN103454432A (zh) * | 2013-09-05 | 2013-12-18 | 苏州照康生物技术有限公司 | 检测c-反应蛋白的免疫比浊试剂盒及其制备方法 |
CN103941017A (zh) * | 2014-03-18 | 2014-07-23 | 北京普恩光德生物科技开发有限公司 | C反应蛋白检测试剂盒 |
CN104515857A (zh) * | 2013-09-30 | 2015-04-15 | 深圳迈瑞生物医疗电子股份有限公司 | 全血c-反应蛋白测量方法、装置及样本分析仪 |
CN105510604A (zh) * | 2016-02-01 | 2016-04-20 | 浙江夸克生物科技有限公司 | 一种提高胶乳试剂灵敏度和线性的方法 |
CN105842458A (zh) * | 2016-03-24 | 2016-08-10 | 山东盛百灵医药科技有限公司 | 一种降钙素原测定试剂盒及其降钙素原的含量的测定方法 |
WO2017107540A1 (zh) * | 2015-12-25 | 2017-06-29 | 广州瑞博奥生物科技有限公司 | 一种检测牙周病相关蛋白的抗体芯片试剂盒 |
CN107340395A (zh) * | 2017-07-05 | 2017-11-10 | 深圳开立生物医疗科技股份有限公司 | 一种检测降钙素原的免疫比浊试剂盒 |
CN107449919A (zh) * | 2017-08-10 | 2017-12-08 | 迈克生物股份有限公司 | 一种c‑反应蛋白检测试剂盒及检测方法 |
CN107656069A (zh) * | 2017-09-28 | 2018-02-02 | 宁波普瑞柏生物技术股份有限公司 | 全血中全量程c‑反应蛋白定量检测试剂及方法 |
WO2018129885A1 (zh) * | 2017-01-13 | 2018-07-19 | 深圳开立生物医疗科技股份有限公司 | 一种全血c反应蛋白检测试剂盒 |
CN108761089A (zh) * | 2018-06-29 | 2018-11-06 | 迈克生物股份有限公司 | 用于检测β2-微球蛋白的试剂的制备方法 |
CN109541241A (zh) * | 2019-01-25 | 2019-03-29 | 浙江夸克生物科技有限公司 | 一种脂蛋白(a)的测定试剂盒 |
CN109856067A (zh) * | 2019-01-11 | 2019-06-07 | 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) | 一种c反应蛋白测定试剂盒 |
CN110095615A (zh) * | 2019-05-27 | 2019-08-06 | 山东艾科达生物科技有限公司 | 一种测定超敏c反应蛋白含量的试剂盒 |
CN111896752A (zh) * | 2020-08-11 | 2020-11-06 | 上海捷门生物技术有限公司 | 一种适用于多种poct类仪器的c-反应蛋白试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1769894A (zh) * | 2004-11-01 | 2006-05-10 | 上海申索佑福医学诊断用品有限公司 | 一种高敏c反应蛋白测定试剂盒 |
-
2010
- 2010-01-26 CN CN 201010103429 patent/CN101769932B/zh active Active
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102841206A (zh) * | 2011-06-22 | 2012-12-26 | 南京诺尔曼生物技术有限公司 | 肌钙蛋白T(Troponin-T,TNT)测定试剂盒 |
CN102841206B (zh) * | 2011-06-22 | 2016-01-20 | 南京诺尔曼生物技术有限公司 | 肌钙蛋白T(Troponin-T,TNT)测定试剂盒 |
CN102680698B (zh) * | 2011-07-29 | 2016-03-30 | 南京诺尔曼生物技术有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白(ngal)测定试剂盒(胶乳增强免疫比浊法) |
CN102680698A (zh) * | 2011-07-29 | 2012-09-19 | 南京诺尔曼生物技术有限公司 | 中性粒细胞明胶酶相关脂质运载蛋白(ngal)测定试剂盒(胶乳增强免疫比浊法) |
CN102565419B (zh) * | 2011-12-26 | 2014-05-14 | 宁波美康生物科技股份有限公司 | 肌红蛋白检测试剂盒 |
CN102565419A (zh) * | 2011-12-26 | 2012-07-11 | 宁波美康生物科技股份有限公司 | 肌红蛋白检测试剂盒 |
CN102590497A (zh) * | 2012-01-13 | 2012-07-18 | 宁波美康生物科技股份有限公司 | 胱氨酸蛋白酶抑制剂c检测试剂盒 |
CN102590497B (zh) * | 2012-01-13 | 2014-01-01 | 宁波美康生物科技股份有限公司 | 胱氨酸蛋白酶抑制剂c检测试剂盒 |
CN102809654A (zh) * | 2012-08-23 | 2012-12-05 | 上海睿康生物科技有限公司 | 一种双粒子复合的c-反应蛋白检测试剂盒 |
CN102955033A (zh) * | 2012-10-22 | 2013-03-06 | 金华市强盛生物科技有限公司 | 一种测定人血液中甘胆酸的试剂盒 |
CN102955033B (zh) * | 2012-10-22 | 2014-08-06 | 金华市强盛生物科技有限公司 | 一种测定人血液中甘胆酸的试剂盒 |
CN102998445A (zh) * | 2012-12-12 | 2013-03-27 | 元升生物科技(上海)有限公司 | 一种测定甘胆酸的试剂及制备方法 |
CN103033629A (zh) * | 2012-12-12 | 2013-04-10 | 元升生物科技(上海)有限公司 | 一种脂蛋白磷脂酶a2的测定试剂及试剂的制备方法 |
CN103018464B (zh) * | 2012-12-12 | 2015-01-07 | 元升生物科技(上海)有限公司 | 一种测定降钙素原的试剂及该试剂的制备方法 |
CN103033629B (zh) * | 2012-12-12 | 2015-02-25 | 元升生物科技(上海)有限公司 | 一种脂蛋白磷脂酶a2的测定试剂及试剂的制备方法 |
CN103018464A (zh) * | 2012-12-12 | 2013-04-03 | 元升生物科技(上海)有限公司 | 一种测定降钙素原的试剂及该试剂的制备方法 |
CN103454432A (zh) * | 2013-09-05 | 2013-12-18 | 苏州照康生物技术有限公司 | 检测c-反应蛋白的免疫比浊试剂盒及其制备方法 |
CN104515857A (zh) * | 2013-09-30 | 2015-04-15 | 深圳迈瑞生物医疗电子股份有限公司 | 全血c-反应蛋白测量方法、装置及样本分析仪 |
CN104515857B (zh) * | 2013-09-30 | 2016-09-14 | 深圳迈瑞生物医疗电子股份有限公司 | 全血c-反应蛋白测量方法、装置及样本分析仪 |
CN103941017A (zh) * | 2014-03-18 | 2014-07-23 | 北京普恩光德生物科技开发有限公司 | C反应蛋白检测试剂盒 |
CN103941017B (zh) * | 2014-03-18 | 2016-01-20 | 北京普恩光德生物科技开发有限公司 | C反应蛋白检测试剂盒 |
WO2017107540A1 (zh) * | 2015-12-25 | 2017-06-29 | 广州瑞博奥生物科技有限公司 | 一种检测牙周病相关蛋白的抗体芯片试剂盒 |
CN105510604A (zh) * | 2016-02-01 | 2016-04-20 | 浙江夸克生物科技有限公司 | 一种提高胶乳试剂灵敏度和线性的方法 |
CN105842458A (zh) * | 2016-03-24 | 2016-08-10 | 山东盛百灵医药科技有限公司 | 一种降钙素原测定试剂盒及其降钙素原的含量的测定方法 |
WO2018129885A1 (zh) * | 2017-01-13 | 2018-07-19 | 深圳开立生物医疗科技股份有限公司 | 一种全血c反应蛋白检测试剂盒 |
CN107340395A (zh) * | 2017-07-05 | 2017-11-10 | 深圳开立生物医疗科技股份有限公司 | 一种检测降钙素原的免疫比浊试剂盒 |
CN107449919B (zh) * | 2017-08-10 | 2019-01-15 | 迈克生物股份有限公司 | 一种c-反应蛋白检测试剂盒及检测方法 |
CN107449919A (zh) * | 2017-08-10 | 2017-12-08 | 迈克生物股份有限公司 | 一种c‑反应蛋白检测试剂盒及检测方法 |
CN107656069A (zh) * | 2017-09-28 | 2018-02-02 | 宁波普瑞柏生物技术股份有限公司 | 全血中全量程c‑反应蛋白定量检测试剂及方法 |
CN108761089A (zh) * | 2018-06-29 | 2018-11-06 | 迈克生物股份有限公司 | 用于检测β2-微球蛋白的试剂的制备方法 |
CN109856067A (zh) * | 2019-01-11 | 2019-06-07 | 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) | 一种c反应蛋白测定试剂盒 |
CN109541241A (zh) * | 2019-01-25 | 2019-03-29 | 浙江夸克生物科技有限公司 | 一种脂蛋白(a)的测定试剂盒 |
CN110095615A (zh) * | 2019-05-27 | 2019-08-06 | 山东艾科达生物科技有限公司 | 一种测定超敏c反应蛋白含量的试剂盒 |
CN111896752A (zh) * | 2020-08-11 | 2020-11-06 | 上海捷门生物技术有限公司 | 一种适用于多种poct类仪器的c-反应蛋白试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN101769932B (zh) | 2013-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101769932B (zh) | 全量程c反应蛋白检测试剂盒 | |
CN102353770B (zh) | 胱氨酸蛋白酶抑制剂c检测试剂盒 | |
WO2018129885A1 (zh) | 一种全血c反应蛋白检测试剂盒 | |
CN102628865B (zh) | 检测肌红蛋白含量的胶乳增强免疫比浊试剂盒 | |
CN102749454B (zh) | 一种全量程c反应蛋白胶体金免疫比浊检测试剂盒 | |
CN102590526B (zh) | β2-微球蛋白检测试剂盒 | |
CN102628867B (zh) | 双抗体胶乳增强视黄醇结合蛋白检测试剂盒 | |
CN105510604A (zh) | 一种提高胶乳试剂灵敏度和线性的方法 | |
CN104215770A (zh) | 一种基于双粒子的视黄醇结合蛋白检测试剂盒 | |
CN102590497A (zh) | 胱氨酸蛋白酶抑制剂c检测试剂盒 | |
CN104034892A (zh) | 一种肿瘤标志物afp磁微粒化学发光免疫分析试剂盒及其检测方法 | |
CN102901812A (zh) | 一种人甲状腺球蛋白抗体(TGAb)的磁微粒化学发光免疫分析试剂盒及其检测方法 | |
CN102565419B (zh) | 肌红蛋白检测试剂盒 | |
CN105203748A (zh) | 一种全量程c反应蛋白的定量检测试剂盒 | |
CN101246163A (zh) | 脓毒症早期诊断液相芯片及其制备方法 | |
CN103645323A (zh) | 一种胱抑素c检测试剂盒及其制备方法 | |
CN108593641A (zh) | 一种定量检测全血样品中待测物质的试剂盒及方法 | |
CN109459570A (zh) | 一种快速检测人体血液中铅离子的胶体金免疫试纸条制备方法 | |
CN109541201A (zh) | 一种提升免疫比浊法准确性的方法 | |
CN108663526B (zh) | 二抗竞争免疫比浊测定试剂盒及其制作和使用方法 | |
CN107942068A (zh) | β2‑微球蛋白测定试剂盒 | |
CN102369441B (zh) | 免疫分析方法及用于该方法的试剂 | |
CN108548927B (zh) | 消除血清脂类干扰的胶乳免疫比浊法胃蛋白酶原ⅱ检测试剂盒及其制备方法 | |
JP5085736B2 (ja) | 複合体の測定方法およびそれに用いるキット | |
JP3513075B2 (ja) | 免疫測定法及びそのための試薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NINGBO MEDICAL SHENGDA SYSTEM BIOTECHNOLOGY CO., L Free format text: FORMER OWNER: MEIKANG BIOTECH CO., LTD., NINGBO Effective date: 20110706 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 315104 NO. 299, QIMING SOUTH ROAD, YINZHOU CENTER DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE TO: 315104 NO. 299, QIMING SOUTH ROAD, YINZHOU DISTRICT, NINGBO CITY, ZHEJIANG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110706 Address after: 315104 Zhejiang city of Ningbo province Yinzhou District Qiming Road No. 299 Applicant after: Ningbo Medical Shengda System Biotechnology Co.,Ltd. Address before: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299 Applicant before: Ningbo Medical System Biotechnology Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: MEIKANG BIOTECH CO., LTD., NINGBO Free format text: FORMER OWNER: NINGBO MEDICAL SHENGDA SYSTEM BIOTECHNOLOGY CO., LTD. Effective date: 20110914 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20110914 Address after: 315104 Zhejiang city of Ningbo province Yinzhou District Qiming Road No. 299 Applicant after: Ningbo Medical System Biotechnology Co.,Ltd. Address before: 315104 Zhejiang city of Ningbo province Yinzhou District Qiming Road No. 299 Applicant before: Ningbo Medical Shengda System Biotechnology Co.,Ltd. |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 315104 Zhejiang city of Ningbo province Yinzhou District Qiming Road No. 299 Applicant after: NINGBO MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. Address before: 315104 Zhejiang city of Ningbo province Yinzhou District Qiming Road No. 299 Applicant before: Ningbo Medical System Biotechnology Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: MEIKANG BIOTECH CO., LTD., NINGBO TO: NINGBO MEDICAL SYSTEM BIOTECHNOLOGY CO., LTD. |
|
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zou Bingde Inventor before: Zou Bingde Inventor before: Xia Jiayin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZOU BINGDE XIA JIAYIN TO: ZOU BINGDE |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 315104 Zhejiang city of Ningbo province Yinzhou District Qiming Road No. 299 Patentee after: MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. Address before: 315104 Zhejiang city of Ningbo province Yinzhou District Qiming Road No. 299 Patentee before: NINGBO MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20100707 Assignee: Ningbo Shengyuan Biotechnology Co., Ltd. Assignor: MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. Contract record no.: X2022330000361 Denomination of invention: Full Scale C-Reactive Protein Assay Kit Granted publication date: 20130918 License type: Common License Record date: 20220809 |
|
EE01 | Entry into force of recordation of patent licensing contract |